Abstract:Coronavirus disease 2019 (COVID-19) is rapidly spreading. Researchers around the world are dedicated to finding the treatment clues for COVID-19. Drug repositioning, as a rapid and cost-effective way for finding therapeutic options from available FDA-approved drugs, has been applied to drug discovery for COVID-19. In this study, we develop a novel drug repositioning method (VDA-KLMF) to prioritize possible anti-SARS-CoV-2 drugs integrating virus sequences, drug chemical structures, known Virus-Drug Associations, and Logistic Matrix Factorization with Kernel diffusion. First, Gaussian kernels of viruses and drugs are built based on known VDAs and nearest neighbors. Second, sequence similarity kernel of viruses and chemical structure similarity kernel of drugs are constructed based on biological features and an identity matrix. Third, Gaussian kernel and similarity kernel are diffused. Forth, a logistic matrix factorization model with kernel diffusion is proposed to identify potential anti-SARS-CoV-2 drugs. Finally, molecular dockings between the inferred antiviral drugs and the junction of SARS-CoV-2 spike protein-ACE2 interface are implemented to investigate the binding abilities between them. VDA-KLMF is compared with two state-of-the-art VDA prediction models (VDA-KATZ and VDA-RWR) and three classical association prediction methods (NGRHMDA, LRLSHMDA, and NRLMF) based on 5-fold cross validations on viruses, drugs, and VDAs on three datasets. It obtains the best recalls, AUCs, and AUPRs, significantly outperforming other five methods under the three different cross validations. We observe that four chemical agents coming together on any two datasets, that is, remdesivir, ribavirin, nitazoxanide, and emetine, may be the clues of treatment for COVID-19. The docking results suggest that the key residues K353 and G496 may affect the binding energies and dynamics between the inferred anti-SARS-CoV-2 chemical agents and the junction of the spike protein-ACE2 interface. Integrating various biological data, Gaussian kernel, similarity kernel, and logistic matrix factorization with kernel diffusion, this work demonstrates that a few chemical agents may assist in drug discovery for COVID-19.

DRaW: prediction of COVID-19 antivirals by deep learning—an objection on using matrix factorization

DeepH-DTA: Deep Learning for Predicting Drug-Target Interactions: A Case Study of COVID-19 Drug Repurposing

Discovery of Potential Therapeutic Drugs for COVID-19 Through Logistic Matrix Factorization with Kernel Diffusion.

DeepVir -- Graphical Deep Matrix Factorization for "In Silico" Antiviral Repositioning: Application to COVID-19

A deep learning method for repurposing antiviral drugs against new viruses via multi-view nonnegative matrix factorization and its application to SARS-CoV-2

A comparative analysis of computational drug repurposing approaches: proposing a novel tensor-matrix-tensor factorization method

Drug Repositioning Based on Similarity Constrained Probabilistic Matrix Factorization: COVID-19 As a Case Study.

DeepCoVDR: Deep Transfer Learning with Graph Transformer and Cross-Attention for Predicting COVID-19 Drug Response.

Viral Drug prediction with Matrix Decomposition and Two-layer Heterogeneous Graph Inference

Predicting drug-target interactions using matrix factorization with self-paced learning and dual similarity information

Predicting Comprehensive Drug-Drug Interactions for New Drugs via Triple Matrix Factorization.

DeepDrug: A General Graph-Based Deep Learning Framework for Drug-Drug Interactions and Drug-Target Interactions Prediction

Predicting potential drug targets and repurposable drugs for COVID-19 via a deep generative model for graphs

A deep drug prediction framework for viral infectious diseases using an optimizer-based ensemble of convolutional neural network: COVID-19 as a case study

Predicting drug-Protein interaction with deep learning framework for molecular graphs and sequences: Potential candidates against SAR-CoV-2

Multiple Similarity Drug-Target Interaction Prediction with Random Walks and Matrix Factorization

A Novel Deep Neural Network Technique for Drug–Target Interaction

A deep learning-based method for drug-target interaction prediction based on long short-term memory neural network

Deep-Learning-Based Drug-Target Interaction Prediction.

Potential SARS-CoV-2 nonstructural proteins inhibitors: drugs repurposing with drug-target networks and deep learning

Large-scale Prediction of Drug-Target Interactions from Deep Representations